{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:21:49Z","timestamp":1778617309965,"version":"3.51.4"},"reference-count":127,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009085","name":"JAIN","doi-asserted-by":"publisher","award":["JU \/MRP\/CNMS\/20\/2022"],"award-info":[{"award-number":["JU \/MRP\/CNMS\/20\/2022"]}],"id":[{"id":"10.13039\/100009085","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.tube.2024.102573","type":"journal-article","created":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T10:08:19Z","timestamp":1730628499000},"page":"102573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Quinoline hybrid derivatives as effective structural motifs in the treatment of tuberculosis: Emphasis on structure-activity relationships"],"prefix":"10.1016","volume":"149","author":[{"given":"Venkatraman","family":"Hegde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raveendra Madhukar","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivasa","family":"Budagumpi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinayak","family":"Adimule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6262-8379","authenticated-orcid":false,"given":"Rangappa S.","family":"Keri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2024.102573_bib1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41579-021-00639-z","article-title":"Infectious disease in an era of global change","volume":"20","author":"Baker","year":"2022","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.tube.2024.102573_bib2","first-page":"187","article-title":"Communicable diseases surveillance lessons learned from developed and developing countries: literature review, Scand","volume":"37","author":"Sahal","year":"2009","journal-title":"J Public Health"},{"key":"10.1016\/j.tube.2024.102573_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/andp.202100482","article-title":"Modelling communicable diseases, human mobility, and epidemics: a review","volume":"534","author":"Soriano-Pa\u00f1os","year":"2022","journal-title":"Ann. Phys.(Berlin)"},{"key":"10.1016\/j.tube.2024.102573_bib4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41579-022-00731-y","article-title":"Anti-tuberculosis treatment strategies and drug development: challenges and priorities","volume":"20","author":"Dartois","year":"2022","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.tube.2024.102573_bib5","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1056\/NEJMc2009939","article-title":"Treatment of highly drug-resistant pulmonary tuberculosis","volume":"382","author":"Bolhuis","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tube.2024.102573_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0270003","article-title":"Risk factors for multidrug-resistant tuberculosis: a worldwide systematic review and meta-analysis","volume":"17","author":"Xi","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2024.102573_bib7","series-title":"Global tuberculosis report 2020","year":"2020"},{"key":"10.1016\/j.tube.2024.102573_bib8","series-title":"Global tuberculosis report 2021: supplementary material","year":"2022"},{"key":"10.1016\/j.tube.2024.102573_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10593-012-0960-z","article-title":"Heterocycles in drugs and drug discovery","volume":"48","author":"Gomtsyan","year":"2012","journal-title":"Chem Heterocycl Compd"},{"key":"10.1016\/j.tube.2024.102573_bib10","series-title":"Heterocyclic chemistry in drug discovery","author":"Li","year":"2013"},{"key":"10.1016\/j.tube.2024.102573_bib11","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.3390\/molecules24213839","article-title":"Heterocycles in medicinal chemistry","volume":"24","author":"Jampilek","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.tube.2024.102573_bib12","doi-asserted-by":"crossref","first-page":"44247","DOI":"10.1039\/D0RA09198G","article-title":"Prescribed drugs containing nitrogen heterocycles: an overview","volume":"10","author":"Heravi","year":"2020","journal-title":"RSC Adv"},{"key":"10.1016\/j.tube.2024.102573_bib13","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.3390\/molecules25081909","article-title":"A Review on recent advances in nitrogen-containing molecules and their biological applications","volume":"25","author":"Kerru","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.tube.2024.102573_bib14","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.biopha.2014.10.007","article-title":"Quinoline: a promising antitubercular target","volume":"68","author":"Keri","year":"2014","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.tube.2024.102573_bib15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1039\/np9850200393","article-title":"Quinoline, quinazoline, and acridone alkaloids","volume":"2","author":"Grundon","year":"1985","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.tube.2024.102573_bib16","series-title":"Quinoline and isoquinolines","author":"Shah","year":"2015"},{"key":"10.1016\/j.tube.2024.102573_bib17","doi-asserted-by":"crossref","first-page":"65496","DOI":"10.1039\/C5RA08778C","article-title":"Antihypertensive activity of a quinoline appended chalcone derivative and its site specific binding interaction with a relevant target carrier protein","volume":"5","author":"Kumar","year":"2015","journal-title":"RSC Adv"},{"key":"10.1016\/j.tube.2024.102573_bib18","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.arabjc.2017.07.006","article-title":"Quinoline derivatives as possible lead compounds for anti-malarial drugs: spectroscopic, DFT and MD study","volume":"13","author":"Sureshkumar","year":"2020","journal-title":"Arab J Chem"},{"key":"10.1016\/j.tube.2024.102573_bib19","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1016\/j.bmc.2019.06.044","article-title":"Biological evaluation of molecules of the azaBINOL class as antiviral agents: inhibition of HIV-1 RNase H activity by 7-isopropoxy-8-(naphth-1-yl)quinoline","volume":"27","author":"Overacker","year":"2019","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.tube.2024.102573_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103310","article-title":"Design, synthesis, biological evaluation, and molecular modeling studies of quinoline-ferulic acid hybrids as cholinesterase inhibitors","volume":"93","author":"Mo","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.tube.2024.102573_bib21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bmcl.2018.11.002","article-title":"Synthesis, antituberculosis studies and biological evaluation of new quinoline derivatives carrying 1,2,4-oxadiazole moiety","volume":"29","author":"Shruthi","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.tube.2024.102573_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.128305","article-title":"Azoimine quinoline derivatives: synthesis, classical and electrochemical evaluation of antioxidant, anti-inflammatory, antimicrobial activities and the DNA\/BSA binding","volume":"1217","author":"Douadi","year":"2020","journal-title":"J Mol Struct"},{"key":"10.1016\/j.tube.2024.102573_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.133634","article-title":"A review: structure-activity relationship and antibacterial activities of Quinoline based hybrids","volume":"1268","author":"Patel","year":"2022","journal-title":"J Mol Struct"},{"key":"10.1016\/j.tube.2024.102573_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2022.108063","article-title":"Novel thieno[2,3-b]quinoline-procaine hybrid molecules: a new class of allosteric SHP-1 activators evolved from PTP1B inhibitors","volume":"34","author":"Xu","year":"2023","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.tube.2024.102573_bib25","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2174\/138945006777709557","article-title":"Quinoline derivatives as promising inhibitors of antibiotic efflux pump in multidrug resistant enterobacter aerogenes isolates","volume":"7","author":"Mahamoud","year":"2006","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.tube.2024.102573_bib26","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1016\/j.ejmech.2009.06.031","article-title":"Synthesis and antimicrobial activities of novel quinoline derivatives carrying 1,2,4-triazole moiety","volume":"44","author":"Eswaran","year":"2009","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.tube.2024.102573_bib27","doi-asserted-by":"crossref","first-page":"S1980","DOI":"10.1016\/j.arabjc.2013.07.026","article-title":"Molecular modeling studies of quinoline derivatives as VEGFR-2 tyrosine kinase inhibitors using pharmacophore based 3D QSAR and docking approach","volume":"10","author":"Ugale","year":"2017","journal-title":"Arab J Chem"},{"key":"10.1016\/j.tube.2024.102573_bib28","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1021\/jm00040a003","article-title":"A new series of PDGF receptor tyrosine kinase inhibitors: 3-substituted quinoline derivatives","volume":"37","author":"Maguire","year":"1994","journal-title":"J Med Chem"},{"key":"10.1016\/j.tube.2024.102573_bib29","article-title":"SAR studies of quinoline and derivatives as potential treatments for Alzheimer's disease","volume":"16","author":"Li","year":"2023","journal-title":"Arab J Chem"},{"key":"10.1016\/j.tube.2024.102573_bib30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1708-8305.1999.tb00843.x","article-title":"Mefloquine for malaria chemoprophylaxis 1992-1998: a Review","volume":"6","author":"Schlagenhauf","year":"1999","journal-title":"J Trav Med"},{"key":"10.1016\/j.tube.2024.102573_bib31","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1039\/b904091a","article-title":"Copper-catalyzed azide-alkyne cycloaddition (CuAAC) and beyond: new reactivity of copper(I) acetylides","volume":"39","author":"Hein","year":"2010","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.tube.2024.102573_bib32","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1021\/jm501881c","article-title":"Origins of the quinolone class of antibacterials: an expanded \u201cdiscovery story","volume":"58","author":"Bisacchi","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.tube.2024.102573_bib33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003495-200262010-00002","article-title":"A critical review of the fluoroquinolones","volume":"62","author":"Zhanel","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.tube.2024.102573_bib34","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ctrv.2006.07.001","article-title":"Irinotecan in the treatment of colorectal cancer","volume":"32","author":"Fuchs","year":"2006","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.tube.2024.102573_bib35","first-page":"259","article-title":"Cabozantinib in thyroid cancer","volume":"10","author":"Fallahi","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.tube.2024.102573_bib36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11912-012-0289-x","article-title":"Cabozantinib as a novel therapy for renal cell carcinoma","volume":"15","author":"Vaishampayan","year":"2013","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.tube.2024.102573_bib37","first-page":"CD000528","article-title":"Drugs for treating Schistosoma mansoni infection","volume":"2","author":"Danso-Appiah","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tube.2024.102573_bib38","unstructured":"G. Jones, Quinolines, Part 1, Volume vol. 32, published by Wiley, ISBN: 978-0-470-18853-8."},{"key":"10.1016\/j.tube.2024.102573_bib39","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00436-006-0192-1","article-title":"Effects of dibucaine on the endocytic\/exocytic pathways in Trypanosoma cruzi","volume":"99","author":"Souto-Padr\u00f3n","year":"2006","journal-title":"Parasitol Res"},{"key":"10.1016\/j.tube.2024.102573_bib40","series-title":"Heterocycles - synthesis and biological activities","article-title":"Quinoline heterocycles: synthesis and bioactivity","author":"Rajesh","year":"2020"},{"issue":"8","key":"10.1016\/j.tube.2024.102573_bib41","first-page":"FM01","article-title":"Bedaquiline: a novel antitubercular agent for the treatment of multidrug- resistant tuberculosis","volume":"10","author":"Yadav","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.tube.2024.102573_bib42","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1021\/jo0204496","article-title":"Synthesis of aminonicotinonitriles and diaminopyridines through base-catalyzed ring transformation of 2 H -pyran-2-ones","volume":"68","author":"Farhanullah","year":"2003","journal-title":"J Org Chem"},{"key":"10.1016\/j.tube.2024.102573_bib43","doi-asserted-by":"crossref","first-page":"15385","DOI":"10.1039\/D2RA01571D","article-title":"Pyridine: the scaffolds with significant clinical diversity","volume":"12","author":"De","year":"2022","journal-title":"RSC Adv"},{"key":"10.1016\/j.tube.2024.102573_bib44","series-title":"Recent developments in the synthesis and applications of pyridines","first-page":"605","article-title":"Synthesis of pyridine derivatives for diverse biological activity profiles: a review","author":"Allaka","year":"2023"},{"key":"10.1016\/j.tube.2024.102573_bib45","series-title":"Synthesis and properties of pyridine containing drugs and heterocycles","author":"Ayed","year":"2017"},{"key":"10.1016\/j.tube.2024.102573_bib46","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1039\/C8MD00480C","article-title":"Quinolone-isoniazid hybrids: synthesis and preliminary in vitro cytotoxicity and anti-tuberculosis evaluation","volume":"10","author":"Beteck","year":"2019","journal-title":"MedChemComm"},{"key":"10.1016\/j.tube.2024.102573_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114531","article-title":"Designing quinoline-isoniazid hybrids as potent anti-tubercular agents inhibiting mycolic acid biosynthesis","volume":"239","author":"Alcaraz","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.tube.2024.102573_bib48","first-page":"117","article-title":"Synthesis and anti-tuberculosis activity of 2,4-disubstituted quinolone","author":"Nayyar","year":"2008","journal-title":"Indian J Chem"},{"key":"10.1016\/j.tube.2024.102573_bib49","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3390\/ph15030272","article-title":"Therapeutic outcomes of isatin and its derivatives against multiple diseases: recent developments in drug discovery","volume":"15","author":"Cheke","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.tube.2024.102573_bib50","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2174\/1871524917666171113124112","article-title":"Isatin: new hope against convulsion","volume":"18","author":"Cheke","year":"2018","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"10.1016\/j.tube.2024.102573_bib51","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1039\/C8MD00585K","article-title":"Isatin and its derivatives: a survey of recent syntheses, reactions, and applications","volume":"10","author":"Varun","year":"2019","journal-title":"MedChemComm"},{"key":"10.1016\/j.tube.2024.102573_bib52","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3390\/ph15050536","article-title":"A mini review on isatin, an anticancer scaffold with potential activities against neglected tropical diseases (NTDs)","volume":"15","author":"Chowdhary","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.tube.2024.102573_bib53","doi-asserted-by":"crossref","first-page":"762","DOI":"10.3390\/molecules21060762","article-title":"Synthesis and cytotoxic activity of biphenylurea derivatives containing indolin-2-one moieties","volume":"21","author":"Eldehna","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.tube.2024.102573_bib54","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/14756366.2018.1462802","article-title":"Synthesis and biological evaluation of certain hydrazonoindolin-2-one derivatives as new potent anti-proliferative agents","volume":"33","author":"Eldehna","year":"2018","journal-title":"J Enzym Inhib Med Chem"},{"key":"10.1016\/j.tube.2024.102573_bib55","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cclet.2016.07.032","article-title":"Isatin hybrids and their anti-tuberculosis activity","volume":"28","author":"Xu","year":"2017","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.tube.2024.102573_bib56","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/jhet.3189","article-title":"Isatin derivatives with potential antitubercular activities","volume":"55","author":"Jiang","year":"2018","journal-title":"J Heterocycl Chem"},{"key":"10.1016\/j.tube.2024.102573_bib57","doi-asserted-by":"crossref","first-page":"8807","DOI":"10.3390\/molecules27248807","article-title":"Development of novel isatin-tethered quinolines as anti-tubercular agents against multi and extensively drug-resistant mycobacterium tuberculosis","volume":"27","author":"Abdelrahman","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.tube.2024.102573_bib58","first-page":"53","article-title":"Design, Synthesis and docking study of some novel isatin- quinoline hybrids as potential antitubercular agents","volume":"14","author":"Maddela","year":"2016","journal-title":"Antiinfect. Agents"},{"key":"10.1016\/j.tube.2024.102573_bib59","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.bmcl.2006.02.065","article-title":"Gatifloxacin derivatives: synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis DNA gyrase","volume":"16","author":"Sriram","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.tube.2024.102573_bib60","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2323\/jgam.52.195","article-title":"Evaluation of antimycobacterial and DNA gyrase inhibition of fluoroquinolone derivatives","volume":"52","author":"Sriram","year":"2006","journal-title":"J Gen Appl Microbiol"},{"key":"10.1016\/j.tube.2024.102573_bib61","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00044-005-0135-x","article-title":"Synthesis, antiviral and antibacterial activities of isatin Mannich bases","volume":"14","author":"Sriram","year":"2005","journal-title":"Med Chem Res"},{"key":"10.1016\/j.tube.2024.102573_bib62","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.1016\/j.bmc.2004.08.028","article-title":"Design, synthesis and biological evaluation of novel non-nucleoside HIV-1 reverse transcriptase inhibitors with broad-spectrum chemotherapeutic properties","volume":"12","author":"Sriram","year":"2004","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.tube.2024.102573_bib63","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000048533","article-title":"Antituberculous activity of norfloxacin Mannich bases with isatin derivatives","volume":"47","author":"Pandeya","year":"2001","journal-title":"Chemotherapy"},{"key":"10.1016\/j.tube.2024.102573_bib64","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/cbdd.12273","article-title":"7\u2010Chloroquinoline-isatin conjugates: antimalarial, antitubercular, and cytotoxic evaluation","volume":"83","author":"Raj","year":"2014","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.tube.2024.102573_bib65","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.ejmech.2017.11.090","article-title":"Synthesis and in vitro evaluation of novel substituted isatin-propylene-1H-1,2,3-triazole-4-methylene-moxifloxacin hybrids for their anti-mycobacterial activities","volume":"143","author":"Yan","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.tube.2024.102573_bib66","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1016\/j.bmcl.2017.07.023","article-title":"Design, synthesis and in vitro anti-mycobacterial evaluation of gatifloxacin-1H-1,2,3-triazole-isatin hybrids","volume":"27","author":"Xu","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.tube.2024.102573_bib67","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1016\/j.ejmech.2010.04.027","article-title":"Synthesis and in vitro antimycobacterial activity of balofloxacin ethylene isatin derivatives","volume":"45","author":"Feng","year":"2010","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.tube.2024.102573_bib68","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ejmech.2010.11.023","article-title":"Synthesis and in vitro antimycobacterial activity of 8-OCH3 ciprofloxacin methylene and ethylene isatin derivatives","volume":"46","author":"Feng","year":"2011","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.tube.2024.102573_bib69","series-title":"Coumarins: biology applications and mode of action","year":"1997"},{"key":"10.1016\/j.tube.2024.102573_bib70","first-page":"9067","article-title":"Review on oxygen heterocycles, Indo American J","volume":"3","author":"Kaur","year":"2013","journal-title":"Pharma Res"},{"key":"10.1016\/j.tube.2024.102573_bib71","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.2174\/092986708786242877","article-title":"A review of coumarin derivatives in pharmacotherapy of breast cancer","volume":"15","author":"Musa","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.tube.2024.102573_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2023.112430","article-title":"A review on applications of coumarin and its derivatives in preparation of photo-responsive polymers","volume":"198","author":"Safavi-Mirmahalleh","year":"2023","journal-title":"Eur Polym J"},{"key":"10.1016\/j.tube.2024.102573_bib73","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1039\/b808333a","article-title":"The aminocoumarins: biosynthesis and biology","volume":"26","author":"Heide","year":"2009","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.tube.2024.102573_bib74","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejmech.2015.06.017","article-title":"Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents","volume":"100","author":"Keri","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.tube.2024.102573_bib75","first-page":"212","article-title":"Coumarin-furoquinoline conjugates as potential antitubercular agents: synthesis, biological evaluation and molecular docking studies","author":"Vimala","year":"2017","journal-title":"J Chem Pharmaceut Res"},{"key":"10.1016\/j.tube.2024.102573_bib76","doi-asserted-by":"crossref","first-page":"6984","DOI":"10.1021\/cr2000459","article-title":"From 2000 to Mid-2010: a fruitful decade for the synthesis of pyrazoles","volume":"111","author":"Fustero","year":"2011","journal-title":"Chem Rev"},{"key":"10.1016\/j.tube.2024.102573_bib77","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3390\/biomedicines10051124","article-title":"A review of the recent development in the synthesis and biological evaluations of pyrazole derivatives","volume":"10","author":"Ebenezer","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.tube.2024.102573_bib78","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0140-6736(02)13571-9","article-title":"Antipyrin and the prevailing epidemic","volume":"135","author":"Jennings","year":"1890","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2024.102573_bib79","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1124\/pr.58.1.6","article-title":"Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.tube.2024.102573_bib80","first-page":"CD004233","article-title":"Single dose oral celecoxib for acute postoperative pain in adults","volume":"10","author":"Derry","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tube.2024.102573_bib81","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1366-0071(97)80033-2","article-title":"The early history of non-opioid analgesics","volume":"1","author":"Brune","year":"1997","journal-title":"Acute Pain"},{"key":"10.1016\/j.tube.2024.102573_bib82","first-page":"699","volume":"vol. 184","author":"Collins","year":"1984"},{"key":"10.1016\/j.tube.2024.102573_bib83","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1039\/C6NJ03181A","article-title":"Shamsuzzaman, Review: biologically active pyrazole derivatives","volume":"41","author":"Ansari","year":"2017","journal-title":"New J Chem"},{"key":"10.1016\/j.tube.2024.102573_bib84","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/ardp.201400452","article-title":"Recent progress on pyrazole scaffold-based antimycobacterial agents","volume":"348","author":"Keri","year":"2015","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.tube.2024.102573_bib85","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000077","article-title":"Pyrazole-coumarin and pyrazole-quinoline chalcones as potential antitubercular agents","volume":"353","author":"Kumar","year":"2020","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1016\/j.tube.2024.102573_bib86","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s42250-019-00096-5","article-title":"Development of antimicrobial, antimalarial and antitubercular compounds based on a quinoline-pyrazole clubbed scaffold derived via Doebner reaction","volume":"3","author":"Pandya","year":"2020","journal-title":"Chem. Africa"},{"key":"10.1016\/j.tube.2024.102573_bib87","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1134\/S1068162023010053","article-title":"Design, synthesis, anti-tubercular evaluation and teratogenicity studies of furanyl pyrazolo[3,4-b] quinoline-5-ones","volume":"49","author":"Babu","year":"2023","journal-title":"Russ J Bioorg Chem"},{"key":"10.1016\/j.tube.2024.102573_bib88","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jfluchem.2016.01.011","article-title":"Synthesis and antitubercular and antibacterial activity of some active fluorine containing quinolone-pyrazole hybrid derivatives","volume":"183","author":"Nayak","year":"2016","journal-title":"J Fluor Chem"},{"key":"10.1016\/j.tube.2024.102573_bib89","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/jhet.3438","article-title":"Glycerol mediated synthesis, biological evaluation, and molecular docking study of 4\u2010(1H \u2010pyrazol\u20104\u2010yl)\u2010polyhydroquinolines as potent antitubercular agents","volume":"56","author":"Jamale","year":"2019","journal-title":"J Heterocycl Chem"},{"key":"10.1016\/j.tube.2024.102573_bib90","doi-asserted-by":"crossref","first-page":"10686","DOI":"10.1039\/C7NJ01962A","article-title":"Synthesis, characterization, in silico molecular docking study and biological evaluation of a 5-(phenylthio) pyrazole based polyhydroquinoline core moiety","volume":"41","author":"Sapariya","year":"2017","journal-title":"New J Chem"},{"key":"10.1016\/j.tube.2024.102573_bib91","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejmech.2014.02.015","article-title":"Synthesis, characterization and pharmacological screening of some novel 5-imidazopyrazole incorporated polyhydroquinoline derivatives","volume":"78","author":"Kalaria","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.tube.2024.102573_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/14756360903524304","article-title":"Pharmacological significance of triazole scaffold","volume":"26","author":"Kharb","year":"2011","journal-title":"J Enzym Inhib Med Chem"},{"key":"10.1016\/j.tube.2024.102573_bib93","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/092986712803414213","article-title":"Recent researches in triazole compounds as medicinal drugs","volume":"19","author":"Zhou","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.tube.2024.102573_bib94","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1021\/acsinfecdis.2c00452","article-title":"A new 1,2,3-triazole scaffold with improved potency against staphylococcus aureus biotin protein ligase","volume":"8","author":"Stachura","year":"2022","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.tube.2024.102573_bib95","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1016\/j.bmcl.2008.04.056","article-title":"Synthesis and SAR studies of biaryloxy-substituted triazoles as antifungal agents","volume":"18","author":"Liu","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.tube.2024.102573_bib96","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/092986712803414213","article-title":"Recent researches in triazole compounds as medicinal drugs","volume":"19","author":"Zhou","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.tube.2024.102573_bib97","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ejmech.2005.12.005","article-title":"Synthesis of 1-[3-(4-benzotriazol-1\/2-yl-3-fluoro-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-3-substituted-thiourea derivatives as antituberculosis agents","volume":"41","author":"Dixit","year":"2006","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.tube.2024.102573_bib98","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0223-5234(00)00144-6","article-title":"Synthesis and antitubercular activity of 3-aryl substituted-2-(1H(2H)benzotriazol-1(2)-yl)acrylonitriles","volume":"35","author":"Sanna","year":"2000","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.tube.2024.102573_bib99","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.bmcl.2010.10.057","article-title":"Conventional and microwave assisted synthesis of 2-oxo-4-substituted aryl-azetidine derivatives of benzotriazole: a new class of biological compounds","volume":"21","author":"Dubey","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.tube.2024.102573_bib100","doi-asserted-by":"crossref","DOI":"10.2174\/1570178614666170710125501","article-title":"Synthesis of coumarin-benzotriazole hybrids and evaluation of their anti-tubercular activity","volume":"15","author":"Ambekar","year":"2017","journal-title":"Lett Org Chem"},{"key":"10.1016\/j.tube.2024.102573_bib101","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1002\/slct.201803946","article-title":"Quinoline\u20131,2,3\u2010triazole hybrids: design and synthesis through click reaction, evaluation of anti\u2010tubercular activity, molecular docking and in silico ADME studies","volume":"4","author":"Reddyrajula","year":"2019","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.tube.2024.102573_bib102","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/j.carres.2011.06.028","article-title":"Synthesis of quinoline coupled [1,2,3]-triazoles as a promising class of anti-tuberculosis agents","volume":"346","author":"Karthik Kumar","year":"2011","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.tube.2024.102573_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126671","article-title":"Synthesis and evaluation of a novel quinoline-triazole analogs for antitubercular properties via molecular hybridization approach","volume":"29","author":"Ramprasad","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.tube.2024.102573_bib104","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1016\/j.bmc.2009.04.069","article-title":"Design, synthesis and biological evaluation of novel triazole, urea and thiourea derivatives of quinoline against Mycobacterium tuberculosis","volume":"17","author":"Upadhayaya","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.tube.2024.102573_bib105","first-page":"8","article-title":"A review on biological importance of pyrimidines in the new era","volume":"8","author":"Sahu","year":"2016","journal-title":"Int J Pharm Pharmaceut Sci"},{"key":"10.1016\/j.tube.2024.102573_bib106","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1021\/ml300134b","article-title":"Quinolinyl pyrimidines: potent inhibitors of NDH-2 as a novel class of anti-TB agents","volume":"3","author":"Shirude","year":"2012","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.tube.2024.102573_bib107","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1021\/acsinfecdis.1c00413","article-title":"Synthesis and in vitro biological evaluation of quinolinyl pyrimidines targeting Type II NADH-Dehydrogenase (NDH-2)","volume":"8","author":"Lu","year":"2022","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.tube.2024.102573_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105173","article-title":"Synthesis, antitubercular, antimicrobial activities and molecular docking study of quinoline bearing dihydropyrimidines","volume":"115","author":"Desai","year":"2021","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.tube.2024.102573_bib109","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1016\/j.bmcl.2014.05.002","article-title":"Studies on molecular properties prediction, antitubercular and antimicrobial activities of novel quinoline based pyrimidine motifs","volume":"24","author":"Desai","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.tube.2024.102573_bib110","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.3390\/ijms19061578","article-title":"Natural products for drug discovery in the 21st century: innovations for novel drug discovery","volume":"19","author":"Thomford","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.tube.2024.102573_bib111","doi-asserted-by":"crossref","first-page":"5550","DOI":"10.1039\/D0QO01574A","article-title":"Recent progress in the total synthesis of pyrrole-containing natural products (2011\u20132020) Org","volume":"8","author":"Singh","year":"2021","journal-title":"Chem. Front."},{"key":"10.1016\/j.tube.2024.102573_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114206","article-title":"Discovery of 3H-pyrrolo[2,3-c]quinolines with activity against Mycobacterium tuberculosis by allosteric inhibition of the glutamate-5-kinase enzyme","volume":"232","author":"Panciera","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.tube.2024.102573_bib113","doi-asserted-by":"crossref","first-page":"462","DOI":"10.2174\/1573406411208030462","article-title":"Structure-activity relationships of pyrrole hydrazones as new anti-tuberculosis agents","volume":"8","author":"Lessigiarska","year":"2012","journal-title":"Med Chem"},{"issue":"15","key":"10.1016\/j.tube.2024.102573_bib114","doi-asserted-by":"crossref","first-page":"10534","DOI":"10.1021\/acs.jmedchem.2c00718","article-title":"Design, synthesis, and biological evaluation of pyrrole-2-carboxamide derivatives as mycobacterial membrane protein large 3 inhibitors for treating drug-resistant tuberculosis","volume":"65","author":"Zhao","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.tube.2024.102573_bib115","doi-asserted-by":"crossref","DOI":"10.1002\/ajoc.202400054","article-title":"Pyrrole-thiazolidin-4-one analogues exhibit promising anti-tuberculosis activity","author":"Ahmed","year":"2024","journal-title":"Asian J. Org. Chem."},{"key":"10.1016\/j.tube.2024.102573_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114404","article-title":"Tapping into the antitubercular potential of 2,5-dimethylpyrroles: a structure-activity relationship interrogation","volume":"237","author":"Semenya","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.tube.2024.102573_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114206","article-title":"Discovery of 3H-pyrrolo[2,3-c]quinolines with activity against Mycobacterium tuberculosis by allosteric inhibition of the glutamate-5-kinase enzyme","volume":"232","author":"Panciera","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.tube.2024.102573_bib118","series-title":"Chemistry and biology of [beta]-lactam antibiotics","year":"1982"},{"key":"10.1016\/j.tube.2024.102573_bib119","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1016\/j.ejmech.2010.09.035","article-title":"2-Azetidinone-A new profile of various pharmacological activities","volume":"45","author":"Mehta","year":"2010","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.tube.2024.102573_bib120","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1007\/s00044-015-1432-7","article-title":"Design, synthesis of quinolinyl Schiff bases and azetidinones as enoyl ACP-reductase inhibitors","volume":"24","author":"Joshi","year":"2015","journal-title":"Med Chem Res"},{"key":"10.1016\/j.tube.2024.102573_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134099","article-title":"New quinoline-thiolactone conjugates as potential antitubercular and antibacterial agents","volume":"1271","author":"Faazil","year":"2023","journal-title":"J Mol Struct"},{"key":"10.1016\/j.tube.2024.102573_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.137255","article-title":"Converging thiolactone and quinoline scaffolds: new potential antitubercular conjugates","volume":"1300","author":"Azeeza","year":"2024","journal-title":"J Mol Struct"},{"key":"10.1016\/j.tube.2024.102573_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113266","article-title":"Antitubercular properties of thiazolidin-4-ones \u2013 a review","volume":"215","author":"Trotsko","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.tube.2024.102573_bib124","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1039\/C6MD00278A","article-title":"Novel tetrazoloquinoline-thiazolidinone conjugates as possible antitubercular agents: synthesis and molecular docking","volume":"7","author":"Subhedar","year":"2016","journal-title":"MedChemComm"},{"key":"10.1016\/j.tube.2024.102573_bib125","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/00397911.2018.1564928","article-title":"Dicationic liquid mediated synthesis of tetrazoloquinolinyl methoxy phenyl 4-thiazolidinones and their antibacterial and antitubercular evaluation","volume":"49","author":"Deshmukh","year":"2019","journal-title":"Synth Commun"},{"key":"10.1016\/j.tube.2024.102573_bib126","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1016\/j.ejmech.2011.07.049","article-title":"Design, synthesis and docking studies of quinoline-oxazolidinone hybrid molecules and their antitubercular properties","volume":"46","author":"Thomas","year":"2011","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.tube.2024.102573_bib127","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3390\/ph15050576","article-title":"New quinolone-urea-benzothiazole hybrids as promising antitubercular agents: synthesis, in vitro antitubercular activity, cytotoxicity studies, and in silico ADME profiling","volume":"15","author":"Moodley","year":"2022","journal-title":"Pharmaceuticals"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979224000994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979224000994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:55:21Z","timestamp":1778615721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979224000994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":127,"alternative-id":["S1472979224000994"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2024.102573","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quinoline hybrid derivatives as effective structural motifs in the treatment of tuberculosis: Emphasis on structure-activity relationships","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2024.102573","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102573"}}